CMC

Understanding Global Regulatory Requirements for Nasal Drug Products

This presentation examines global regulatory requirements along with regulatory approaches for bioequivalence and an overview of FDA drug specific guidance.

bcnorris 2017-11-19T01:10:36-05:00 April 8th, 2016|Categories: Presentations, Resources|Tags: ANVISA, Bioequivalence, CMC, EMA, FDA, Nasal Drug Products, Regulatory, regulatory global requirements|

This Is A Custom Widget

This Is A Custom Widget